Continuous Glucose Monitoring (CGM) Devices Market by Component (Transmitters, Receivers, Insulin Pumps and Sensors) and by Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa)- Size, Share, Trends, and Forecast, 2022 -

Continuous Glucose Monitoring (CGM) Devices Market by Component (Transmitters, Receivers, Insulin Pumps and Sensors) and by Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa)- Size, Share, Trends, and Forecast, 2022 - 2028

The continuous glucose monitoring (CGM) devices provide insights about the glucose levels of the diabetic patient throughout the day. CGM is mostly used by patients with type 1 and type 2 diabetes for better glucose control to improve the health and quality of their lives. Moreover, the integration of smartphone for easy diabetes management and cloud based data storage are the key features of the currently available CGM devices which have contributed to the drastic adoption of the CGM systems. The CGM devices displays a complete picture of glucose trends with a graphical display and customizable alerts to indicate the disturbances in glucose status.
Market Dynamics
The major factors driving growth of the continuous glucose monitoring (CGM) devices market include rapid technological advancements and convenience offered by the continuous glucose monitoring devices over the self-monitoring devices such as minimized finger pricks and special software for data tracking.
Moreover, the rising adoption of the CGM devices for gestational diabetes monitoring in pregnant women is expected to accelerate the demand for continuous glucose monitoring devices in the forecast period as diabetes management is important with respect to the pregnancy outcomes. According to the survey by Diabetes Digital Media Ltd., 2016, gestational diabetes is estimated to account for 3-5% of all pregnancies, i.e., 1 in 20 pregnant women will develop gestational diabetes globally.
However, A CGM system is more expensive than using a standard glucose meter as the sensor lifetime is a major factor affecting the cost, inconvenience and user acceptance. Also, health plans, insurance companies, and governments in most countries do not provide reimbursement for CGM, thus the patients have become reluctant towards the adoption of CGM, which costs approximately US$ 3,000 per year per patient, thus restraining market growth.
Key features of the study:
This report provides in-depth analysis of continuous glucose monitoring (CGM) devices market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2022 - 2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global continuous glucose monitoring (CGM) devices market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as a part of this study include Medtronic, Dexcom, Inc., Abbott Laboratories, Medtrum Technologies, Inc., Tandem Diabetes Care, Senseonics, Glycens, Insulet Corporation, and Nemaura Medical, Inc., STMicroelectronics, NXP Semiconductors, Qualcomm, Taiwan Semiconductor Manufacturing Company Limited, GE Healthcare, Microchip Technology Inc., Texas Instruments Inc. and Micron Technology Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
The global continuous glucose monitoring (CGM) devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the continuous glucose monitoring (CGM) devices market
Detailed Segmentation:
Global Continuous Glucose Monitoring (CGM) Devices Market, By Component:
Transmitters
Receivers
Insulin Pumps
Sensors
Global Continuous Glucose Monitoring (CGM) Devices Market, By Geography:
North America
By Component:
Transmitters
Receivers
Insulin Pumps
Sensors
By Country:
U.S.
Canada
Latin America
By Component:
Transmitters
Receivers
Insulin Pumps
Sensors
By Country:
Brazil
Mexico
Rest of Latin America
Europe
By Component:
Transmitters and Receivers
Insulin Pumps
Sensors
By Country:
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Component:
Transmitters
Receivers
Insulin Pumps
Sensors
By Country:
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Component:
Transmitters
Receivers
Insulin Pumps
Sensors
By Country:
GCC
Israel
Rest of Middle East
Africa
By Component:
Transmitters
Receivers
Insulin Pumps
Sensors
By Country:
South Africa
Central Africa
North Africa
Company Profiles
Medtronic *
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
Dexcom, Inc.
Abbott Laboratories
Medtrum Technologies, Inc.
Tandem Diabetes Care
Senseonics
Glycens
Insulet Corporation
Nemaura Medical, Inc.
STMicroelectronics
NXP Semiconductors
Qualcomm
Taiwan Semiconductor Manufacturing Company Limited
GE Healthcare
Microchip Technology Inc.
Texas Instruments Inc.
Micron Technology Inc.
“*” marked represents similar segmentation in other categories in the respective section.